Modulation by lipid mediators of immune complex-induced lung inflammation in mice

European Journal of Pharmacology

Volumn 361, Issue 1, 1998, Pages 93-99

  Steil, Ana A ^a   Tavares De Lima, Wothan ^b   Jancar, Sonia ^b  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arthus reaction; Eicosanoid; Hemorrhagic lesion; Leukotriene B4; Neutrophil; Pneumonitis

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ANTIBODY; BEPAFANT; BOVINE SERUM ALBUMIN; HEMOGLOBIN; ICOSANOID; INDOMETACIN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LEUKOTRIENE C4; LEUKOTRIENE D4; LIPID; PROSTAGLANDIN E2; RO 0254094; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHUS REACTION; AZEPINES; BENZOPYRANS; BLOOD VESSELS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSANOIDS; HEMOGLOBINS; IMMUNE COMPLEX DISEASES; INDOLES; INDOMETHACIN; LIPOXYGENASE INHIBITORS; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NEUTROPHILS; PEROXIDASE; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; PNEUMONIA; RECEPTORS, LEUKOTRIENE B4; SPECIES SPECIFICITY; TRIAZOLES;

EID: 0031722355     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00680-3     Document Type: Article

References (34)

1. Arthus M. Injections repétés de serum de cheval chez le lapin. C.R. Seances Soc. Biol. Paris. 55:1903;817-822.
2. Boughton-Smith N.K., Deakin A.M., Follefant R.L., Whittle B.J.R., Garland L.G. Role of the oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br. J. Pharmacol. 110:1993;896-902.
3. Bozic C.R., Lu B., Hopken U.E., Gerard C., Gerard N.P. Neurogenic amplification of immune complex inflammation. Science. 273:1996;1722-1725.
4. Brieland J.K., Kunkel R.G., Fantone J.C. Pulmonary alveolar macrophage function during acute inflammatory lung injury. Am. Rev. Respir. Dis. 135:1987;1300-1306.
5. Cochrane C.G., Aikin B.S. Polymorphonuclear leukocytes in immunologic reactions. The destructions of vascular basement membrane 'in vivo' and 'in vitro'. J. Exp. Med. 124:1996;733-752.
6. Finnegan M.J., Pickering C.A.C., Davies P.S. Factors affecting the development of precipitating antibodies in workers exposed to contaminated humidifiers. Clin. Allergy. 15:1985;281-292.
7. Gillard J., Ford-Hutchinson A.W., Chan C., Charleson S., Denis D., Foster A., Fortin R., Leger S., McFarlane G.S., Mrton H.E., Piechutta H., Riendeau D., Rouzer C.A., Rokach J., Young R. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-et al. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyil thiol-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. 67:1989;456-464.
8. Hellewell P.G., Williams T.J. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin. J. Immunol. 137:1986;302-307.
9. Henson P.M., Zanolari B., Schwartzman N.A., Hong S.R. Intracellular control of human neutrophil secretion: I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin. Br. J. Immunol. 121:1978;851-855.
10. Heuer H., Casals-Stenzel J., Muacevic G., Weber K.H. Effect of WEB 2170 and STY 2108 two hetrazepins with antagonistic activity on PAF-induced changes 'in vitro' and 'in vivo'. Clin. Exp. Pharmacol. Physiol. 13:1986;7-15.
11. Ierino F.L., Powell M.S., McKenzie I.F.C., Hogarth P.M. Recombinant soluble human FcγRII: production, characterization, and inhibition of the Arthus reaction. J. Exp. Med. 178:1993;1617-1628.
12. Jancar S., De Giaccobi G., Mariano M., Mencia-Huerta J.M., Sirois P., Braquet P. Immune complex induced pancreatitis: effect of BN-52021, a selective antagonist of platelet-activating factor. Prostaglandins. 35:1988;757-770.
13. Johnson K.J., Ward P.A. Acute immunologic pulmonary alveolitis. J. Clin. Invest. 54:1974;349-357.
14. Mulligan M.S., Ward P.A. Immune complex-induced lung and dermal vascular injury differing requirements of tumor necrosis factor-α and IL-1. J. Immunol. 149:1992;331-339.
15. Mulligan M.S., Watson S.R., Fennie C.M.A., Ward P.A. Protective effects of selectin chimeras in neutrophil-mediated lung injury. J. Immunol. 151:1993;6410-6417.
16. Mulligan M.S., Vaporciyan A.A., Warner R.L., Jones M.L., Foreman K.E., Miyasaka M., Todd R.F. III, Ward P.A. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. J. Immunol. 154:1995;1350-1363.
17. Parker, J.P., Petsonk, E.L., Weber, S.L., 1992. Hypersensitivity pneumonitis and organic dust toxic syndrome. In: Banks, E.D. (Ed.), Immunology and Allergy Clinics of North America, Vol. 12, No. 2. W.B. Saunders, pp. 279-290.
18. Pepys, J., 1969. Hypersensitivity diseases of the lungs due to fungi and organic dusts. In: Kallós, P., Hasek, M., Inderbitzin, T.M., Miescher, P.A., Waksman, B.H. (Eds.), Monographs in Allergy, Vol. 4. S. Karger, New York, NY, pp. 69-147.
19. Rossi A.G., Norman K.E., Donigi-Gale D., Shoupe T.S., Edwards R., Williams T.J. The role of complement, platelet-activating factor and leukotriene B4 in the reversed passive Arthus reaction. Br. J. Pharmacol. 107:1992;44-49.
20. Shanley T.P., Schmal H., Warner R.L., Schmid E., Friedl H.P., Ward P.A. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J. Immunol. 158:1997;3439-3448.
21. Steil A.A., Garcia Rodriguez M.C., Alonso A., Sanchez Crespo M., Boscá L. Platelet-activating factor is the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis. Br. J. Pharmacol. 114:1995;859-901.
22. Stetson C.A. Jr. Similarities in the mechanism determining the Arthus and Shwartzman phenomenon. J. Exp. Med. 94:1951;347-357.
23. Tavares de Lima W., Teixeira C.P.F., Sirois P., Jancar S. Involvement of eicosanoids and PAF in immune-complex alveolitis. Braz. J. Med. Biol. Res. 22:1989;745-748.
24. Tavares de Lima W., Sirois P., Jancar S. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions. Eur. J. Pharmacol. 213:1992;63-70.
25. Tavares de Lima W., Steil A.A., Russo M., Starobinas N., Teixeira C.F.P., Jancar S. Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury. Eur. J. Pharmacol. 358:1998;69-75.
26. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 231:1971;232-235.
27. Vásquez-Bravo Y.L.A.R., Russo M., Jancar S. Differential sensitivity of mouse strains to PAF-induced vasopermeability and mortality: effect of antagonists. J. Lipid Mediat. 8:1993;135-144.
28. Ward P.A. Oxygen radicals, cytokines, adhesion molecules, and lung injury. Environ. Health Perspect. 102:1994;13-16.
29. Warren J.S. Relationship between interleukin-1β and platelet-activating factor in the pathogenesis of the acute immune complex alveolitis in the rat. Am. J. Pathol. 141:1992;551-560.
30. Warren J.S., Yabroff K.R., Remick S.L., Kunkel D.G., Chensue S.W., Kunkel R.G., Johnson K.J., Ward P.A. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84:1989;1873-1882.
31. Wilhelm D.L., Mill P.J., Sparrow E., Mackay M.E., Miles A.A. Enzyme-like globulins from sorum reproducing the vascular phenomena of inflammation: IV. Activable permeability factor and its inhibitor in the serum of rat and rabbit. Br. J. Exp. Pathol. 39:1958;228-250.
32. Williams T.J., Jose P.J. Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J. Exp. Med. 153:1981;136-153.
33. 4 receptor. Prost. Leuk. Essent. Fatty Acids. 52:1995;293-297.
34. Zhang Y., Ramos B.J., Jakschik B.A. Augmentation of reversed Arthus Reaction by mast cells in mice. J. Clin. Invest. 88:1991;841-846.